Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Happier countries, longer lives: an ecological study on the relationship between subjective sense of well-being and life expectancy.

Evans GF, Soliman EZ.

Glob Health Promot. 2019 Jun;26(2):36-40. doi: 10.1177/1757975917714035. Epub 2017 Aug 8.

PMID:
28786746
2.

Feasibility of Using Mobile ECG Recording Technology to Detect Atrial Fibrillation in Low-Resource Settings.

Evans GF, Shirk A, Muturi P, Soliman EZ.

Glob Heart. 2017 Dec;12(4):285-289. doi: 10.1016/j.gheart.2016.12.003. Epub 2017 Mar 13.

PMID:
28302547
3.

Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition.

Falcon BL, O'Clair B, McClure D, Evans GF, Stewart J, Swearingen ML, Chen Y, Allard K, Lee LN, Neote K, McEwen DP, Uhlik MT, Chintharlapalli S.

J Hematol Oncol. 2013 Apr 27;6:31. doi: 10.1186/1756-8722-6-31.

4.

Inhibition of glycinamide ribonucleotide formyltransferase results in selective inhibition of macrophage cytokine secretion in vitro and in vivo efficacy in rat adjuvant arthritis.

Chintalacharuvu S, Evans GF, Shih C, Bryant HU, Sandusky GE, Zuckerman SH.

Clin Exp Rheumatol. 2005 Jul-Aug;23(4):438-46.

PMID:
16095110
5.

Post-transcriptional regulation of macrophage ABCA1, an early response gene to IFN-gamma.

Alfaro Leon ML, Evans GF, Farmen MW, Zuckerman SH.

Biochem Biophys Res Commun. 2005 Jul 29;333(2):596-602.

PMID:
15946645
7.

Histone deacetylase inhibition results in decreased macrophage CD9 expression.

Wang XQ, Alfaro ML, Evans GF, Zuckerman SH.

Biochem Biophys Res Commun. 2002 Jun 14;294(3):660-6.

PMID:
12056820
9.

Interferon-gamma-mediated downregulation of cholesterol efflux and ABC1 expression is by the Stat1 pathway.

Wang XQ, Panousis CG, Alfaro ML, Evans GF, Zuckerman SH.

Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):e5-9.

PMID:
12006410
10.

Down-regulation of macrophage CD9 expression by interferon-gamma.

Wang XQ, Evans GF, Alfaro ML, Zuckerman SH.

Biochem Biophys Res Commun. 2002 Jan 25;290(3):891-7.

PMID:
11798156
11.

The diagnostic accuracy of mammography in the evaluation of male breast disease.

Evans GF, Anthony T, Turnage RH, Schumpert TD, Levy KR, Amirkhan RH, Campbell TJ, Lopez J, Appelbaum AH.

Am J Surg. 2001 Feb;181(2):96-100. Erratum in: Am J Surg 2001 Jun;181(6):579.

PMID:
11425067
12.

The relationships between personal PM exposures for elderly populations and indoor and outdoor concentrations for three retirement center scenarios.

Rodes CE, Lawless PA, Evans GF, Sheldon LS, Williams RW, Vette AF, Creason JP, Walsh D.

J Expo Anal Environ Epidemiol. 2001 Mar-Apr;11(2):103-15.

13.

MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation.

Weatherall PT, Evans GF, Metzger GJ, Saborrian MH, Leitch AM.

J Magn Reson Imaging. 2001 Jun;13(6):868-75.

PMID:
11382946
14.

The 1999 Fresno particulate matter exposure studies: comparison of community, outdoor, and residential PM mass measurements.

Evans GF, Highsmith RV, Sheldon LS, Suggs JC, Williams RW, Zweidinger RB, Creason JP, Walsh D, Rodes CE, Lawless PA.

J Air Waste Manag Assoc. 2000 Nov;50(11):1887-96.

PMID:
11111333
15.

Estrogen-mediated increases in LDL cholesterol and foam cell-containing lesions in human ApoB100xCETP transgenic mice.

Zuckerman SH, Evans GF, Schelm JA, Eacho PI, Sandusky G.

Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1476-83.

PMID:
10364078
16.

Mammographic appearances of male breast disease.

Appelbaum AH, Evans GF, Levy KR, Amirkhan RH, Schumpert TD.

Radiographics. 1999 May-Jun;19(3):559-68.

PMID:
10336188
17.

Submaximal delayed-onset muscle soreness: correlations between MR imaging findings and clinical measures.

Evans GF, Haller RG, Wyrick PS, Parkey RW, Fleckenstein JL.

Radiology. 1998 Sep;208(3):815-20.

PMID:
9722865
19.

In vivo dexamethasone effects on neutrophil effector functions in a rat model of acute lung injury.

O'Leary EC, Evans GF, Zuckerman SH.

Inflammation. 1997 Dec;21(6):597-608.

PMID:
9429907
22.

Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia.

Zuckerman SH, Ahmari SE, Bryan-Poole N, Evans GF, Short L, Glasebrook AL.

Inflammation. 1996 Dec;20(6):581-97.

PMID:
8979148
23.

The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.

Apelgren LD, Bailey DL, Fouts RL, Short L, Bryan N, Evans GF, Sandusky GE, Zuckerman SH, Glasebrook A, Bumol TF.

Cell Immunol. 1996 Oct 10;173(1):55-63.

PMID:
8871601
24.
25.
26.
27.

Exogenous glucocorticoids increase macrophage secretion of apo E by cholesterol-independent pathways.

Zuckerman SH, Evans GF, O'Neal L.

Atherosclerosis. 1993 Oct;103(1):43-54.

PMID:
8280184
28.

Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta.

Zuckerman SH, Evans GF, O'Neal L.

Atherosclerosis. 1992 Oct;96(2-3):203-14.

PMID:
1466652
29.
30.

Transcriptional inhibition of endotoxin-induced monokine synthesis following heat shock in murine peritoneal macrophages.

Snyder YM, Guthrie L, Evans GF, Zuckerman SH.

J Leukoc Biol. 1992 Feb;51(2):181-7.

PMID:
1431555
31.

Dielectric properties of the system bovine albumin: urea: betaine in aqueous solution.

Bateman JB, Evans GF, Brown PR, Gabriel C, Grant EH.

Phys Med Biol. 1992 Jan;37(1):175-82.

PMID:
1741422
32.

Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance.

Evans GF, Zuckerman SH.

Eur J Immunol. 1991 Sep;21(9):1973-9.

PMID:
1716205
34.
35.

Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models.

Evans GF, Snyder YM, Butler LD, Zuckerman SH.

Circ Shock. 1989 Dec;29(4):279-90.

PMID:
2598414
36.
37.

Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression.

Zuckerman SH, Evans GF, Snyder YM, Roeder WD.

J Immunol. 1989 Aug 15;143(4):1223-7.

PMID:
2501392
38.

Montana state university: an employee wellness program financed by a self-insurance group health plan.

Evans GF, Harris P, McNeill AW, McKenzie RD.

Am J Health Promot. 1989 Spring;3(4):25-33. doi: 10.4278/0890-1171-3.4.25. No abstract available.

PMID:
22206392
40.

The Texas Natural Death Act.

Evans GF Jr.

Tex Med. 1988 Feb;84(2):37-41. No abstract available.

PMID:
3344517
41.

Helminthiasis in West Virginia.

Evans GF.

W V Med J. 1967 Apr;63(4):125. No abstract available.

PMID:
5233008
42.

SOME PROBLEMS IN MEDICAL LICENSING IN WEST VIRGINIA.

EVANS GF.

W V Med J. 1964 Jun;60:161-3. No abstract available.

PMID:
14153201
43.

RESEARCH IN POPULATION GENETICS OF PRIMITIVE GROUPS. REPORT OF A WHO SCIENTIFIC GROUP.

EVANS GF.

World Health Organ Tech Rep Ser. 1964;279:3-26. No abstract available.

PMID:
14153202
44.

Medical freedom through medical service.

EVANS GF.

W V Med J. 1959 Oct;55:351-4. No abstract available.

PMID:
13820986
45.

The acute need for physicians at mental institutions in West Virginia.

EVANS GF.

W V Med J. 1957 Jun;53(6):233-4. No abstract available.

PMID:
13434111
46.

Multiple cutaneous effects of potassium sulfocyanate; report of a case.

HOLLANDER L, EVANS GF, KRUGH FJ.

Arch Derm Syphilol. 1949 Jan;59(1):112-4. No abstract available.

PMID:
18110571

Supplemental Content

Loading ...
Support Center